EQS-News

Volta Medical Featured in Latest Consensus Statement from Leading International Cardiac Electrophysiology Societies on Atrial Fibrillation Ablation

EQS-News: Volta Medical SAS / Key word(s): Miscellaneous Volta Medical Featured in Latest Consensus Statement from Leading International Cardiac Electrophysiology Societies on Atrial Fibrillation Ablation 09.05.2024 / 14:00 CET/CEST The issuer is solely responsible for the content of this announcement. Volta Medical Featured in Latest Consensus Statement from Leading International Cardiac Electrophysiology Societies on Atrial Fibrillation Ablation

• Published in the EP Europace Journal, the consensus statement highlights Volta’s AI Companion and the TAILORED-AF clinical trial.

Marseille (France), May 9, 2024 – Volta Medical, a pioneering health technology company developing artificial intelligence (AI) solutions to assist electrophysiologists, today announced that the company’s AI companion technology and the TAILORED-AF clinical trial have been featured in the latest consensus statement released by leading global cardiac electrophysiology societies. This statement focuses on advancements in managing catheter and surgical treatments for atrial fibrillation (AF). Volta’s AI companion is a software solution designed to assist electrophysiologists in real-time assessment of dispersed electrograms (EGMs). The TAILORED-AF clinical trial was designed to determine if a tailored AI software-guided ablation procedure in combination with pulmonary vein isolation is superior to a conventional anatomical ablation procedure. Clinical results will be published soon and shared with the scientific community.    

"We are proud that Volta’s spatio-temporal dispersion-guided AI solution is included in the latest consensus statement on atrial fibrillation ablation. Particularly, the document describes the TAILORED-AF trial protocol and its anticipated impact on clinical practice. Acknowledgement of our TAILORED-AF trial by leading experts in the field validates our relentless dedication to empowering physicians with innovative solutions and driving transformative progress in healthcare.” said Dr. Jérôme Kalifa, MD, PhD, Volta Medical Chief Medical Officer and co-founder.